Dhillon Punit's Form 4 filing
Skye Bioscience, Inc. (SKYE) · filed Aug 29, 2023
- Accession no.
- 0001516551-23-000062
- Filed
- Aug 29, 2023, 6:39 PM ET
- Trade date
- Aug 23-29, 2023
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market purchases total $16.5K. It was filed 6 days after the trade, past the 2-business-day deadline.
This filing was later replaced by the amendment 0001516551-23-000069 (Aug 31, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dhillon PunitCIK 0001425052 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2023 | Common Stock | AGrant or awardAcquired | +20,277,414 | –F2 | – | 40,554,828 | Direct | |
| Aug 23, 2023 | Common Stock | LLess common codeAcquired | +9,000 | $0.0118 | +$106.2 | 40,563,828 | Direct | |
| Aug 28, 2023 | Common Stock | LLess common codeAcquired | +110,000 | $0.0171 | +$1,881 | 40,673,828 | Direct | |
| Aug 29, 2023 | Common Stock | PPurchaseAcquired | +881,000 | $0.0187 | +$16,474.7 | 41,554,828 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2023 | Common Stock | AGrant or awardAcquired | +2,253,046 | $0.00 | $0 | 2,253,046 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Referenced by the price of 1 transaction in Table I.